|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2010-4-14
|
|
pubmed:abstractText |
The functional characterization of secreted peptides can provide the basis for the development of novel therapeutic agents. Augurin is a recently identified secreted peptide of unknown function expressed in multiple endocrine tissues, and in regions of the brain including the hypothalamus. We therefore investigated the effect of hypothalamic injection of augurin on the hypothalamo-pituitary-adrenal (HPA) axis in male Wistar rats.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-10823952,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-10920976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-12399416,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-12639925,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-12800218,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-12867498,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-12933668,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-15075390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-15890775,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-16236742,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-1654420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-16574794,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-17284679,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-19883461,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-6774363,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-7479843,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-8484004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-8620137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20233222-8977423
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1476-5381
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
159
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1663-71
|
|
pubmed:dateRevised |
2011-7-27
|
|
pubmed:meshHeading |
pubmed-meshheading:20233222-Animals,
pubmed-meshheading:20233222-Behavior, Animal,
pubmed-meshheading:20233222-Corticotropin-Releasing Hormone,
pubmed-meshheading:20233222-Hormones,
pubmed-meshheading:20233222-Humans,
pubmed-meshheading:20233222-Hypothalamo-Hypophyseal System,
pubmed-meshheading:20233222-Injections, Intraventricular,
pubmed-meshheading:20233222-Male,
pubmed-meshheading:20233222-Neoplasm Proteins,
pubmed-meshheading:20233222-Pituitary-Adrenal System,
pubmed-meshheading:20233222-Rats,
pubmed-meshheading:20233222-Rats, Wistar
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats.
|
|
pubmed:affiliation |
Department of Investigative Medicine, Imperial College London, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
